Tapewire

Nasdaq · USD

AGIO

AGIOS PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
4499
SEC CIK
0001439222
Parsed reports
520

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202506
Jan 202601
Feb 202600
Mar 2026021
Apr 202607
May 202600
Jun 202600
Jul 202601
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 20, 2025 Filed Jun 23, 2025 20:18 UTC Exercise / conversionCommon stock 2,120 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000049 · wk-form4_1750709929.xml · nonDerivative · entry 1

Scadden David · CIK 0001707715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,603

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:20 UTC GrantStock options (right to buy) · Derivative 15,768 $0.00 Strike: $35.50 $0.00
Disclosure

SEC source: 0001439222-25-000051 · wk-form4_1750710009.xml · derivative · entry 3

Owen Adams Catherine · CIK 0001816838 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,768

Underlying: Common stock · 15,768 shares

Expires 2035-06-18

F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:20 UTC GrantRestricted stock units · Derivative 2,816 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000051 · wk-form4_1750710009.xml · derivative · entry 2

Owen Adams Catherine · CIK 0001816838 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,816

Underlying: Common stock · 2,816 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:27 UTC GrantStock options (right to buy) · Derivative 15,768 $0.00 Strike: $35.50 $0.00
Disclosure

SEC source: 0001439222-25-000061 · wk-form4_1750710427.xml · derivative · entry 3

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,768

Underlying: Common stock · 15,768 shares

Expires 2035-06-18

F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:27 UTC GrantRestricted stock units · Derivative 2,816 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000061 · wk-form4_1750710427.xml · derivative · entry 2

Ballal Rahul D. · CIK 0001805097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,816

Underlying: Common stock · 2,816 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:25 UTC GrantStock options (right to buy) · Derivative 15,768 $0.00 Strike: $35.50 $0.00
Disclosure

SEC source: 0001439222-25-000059 · wk-form4_1750710331.xml · derivative · entry 3

CAPELLO JEFFREY D · CIK 0001224108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,768

Underlying: Common stock · 15,768 shares

Expires 2035-06-18

F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying this option vest as to 100% of the underlying shares on June 18, 2026.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:25 UTC GrantRestricted stock units · Derivative 2,861 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000059 · wk-form4_1750710331.xml · derivative · entry 2

CAPELLO JEFFREY D · CIK 0001224108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,861

Underlying: Common stock · 2,861 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:24 UTC GrantStock options (right to buy) · Derivative 15,768 $0.00 Strike: $35.50 $0.00
Disclosure

SEC source: 0001439222-25-000057 · wk-form4_1750710263.xml · derivative · entry 4

Foster-Cheek Kaye I · CIK 0001312622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,768

Underlying: Common stock · 15,768 shares

Expires 2035-06-18

F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:24 UTC GrantRestricted stock units · Derivative 2,816 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000057 · wk-form4_1750710263.xml · derivative · entry 3

Foster-Cheek Kaye I · CIK 0001312622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,816

Underlying: Common stock · 2,816 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:23 UTC GrantStock options (right to buy) · Derivative 15,768 $0.00 Strike: $35.50 $0.00
Disclosure

SEC source: 0001439222-25-000055 · wk-form4_1750710197.xml · derivative · entry 3

FOUSE JACQUALYN A · CIK 0001405288 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,768

Underlying: Common stock · 15,768 shares

Expires 2035-06-18

F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:23 UTC GrantRestricted stock units · Derivative 2,816 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000055 · wk-form4_1750710197.xml · derivative · entry 2

FOUSE JACQUALYN A · CIK 0001405288 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,816

Underlying: Common stock · 2,816 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:21 UTC
Ho MaykinDirector
GrantStock options (right to buy) · Derivative 15,768 $0.00 Strike: $35.50 $0.00
Disclosure

SEC source: 0001439222-25-000053 · wk-form4_1750710074.xml · derivative · entry 3

Ho Maykin · CIK 0001646395 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,768

Underlying: Common stock · 15,768 shares

Expires 2035-06-18

F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:21 UTC
Ho MaykinDirector
GrantRestricted stock units · Derivative 2,816 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000053 · wk-form4_1750710074.xml · derivative · entry 2

Ho Maykin · CIK 0001646395 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,816

Underlying: Common stock · 2,816 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:17 UTC GrantStock options (right to buy) · Derivative 15,768 $0.00 Strike: $35.50 $0.00
Disclosure

SEC source: 0001439222-25-000047 · wk-form4_1750709855.xml · derivative · entry 3

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,768

Underlying: Common stock · 15,768 shares

Expires 2035-06-18

F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:17 UTC GrantRestricted stock units · Derivative 2,816 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000047 · wk-form4_1750709855.xml · derivative · entry 2

Smith Cynthia · CIK 0001609480 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,816

Underlying: Common stock · 2,816 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:18 UTC GrantStock options (right to buy) · Derivative 15,768 $0.00 Strike: $35.50 $0.00
Disclosure

SEC source: 0001439222-25-000049 · wk-form4_1750709929.xml · derivative · entry 3

Scadden David · CIK 0001707715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,768

Underlying: Common stock · 15,768 shares

Expires 2035-06-18

F3 · derivative.exercise_date: These options were granted on June 18, 2025. The shares underlying these options vest as to 100% of the underlying shares on June 18, 2026.

Read SEC document
June 18, 2025 Filed Jun 23, 2025 20:18 UTC GrantRestricted stock units · Derivative 2,816 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000049 · wk-form4_1750709929.xml · derivative · entry 2

Scadden David · CIK 0001707715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,816

Underlying: Common stock · 2,816 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 18, 2025. The shares underlying the stock units will vest in full on June 18, 2026. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:15 UTC Exercise / conversionRestricted stock units · Derivative 1,977 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000043 · wk-form4_1750191300.xml · derivative · entry 2

Owen Adams Catherine · CIK 0001816838 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,976

Underlying: Common stock · 1,977 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:15 UTC Exercise / conversionCommon stock 1,977 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000043 · wk-form4_1750191300.xml · nonDerivative · entry 1

Owen Adams Catherine · CIK 0001816838 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,953

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:16 UTC Exercise / conversionRestricted stock units · Derivative 1,977 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000045 · wk-form4_1750191390.xml · derivative · entry 2

CAPELLO JEFFREY D · CIK 0001224108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,976

Underlying: Common stock · 1,977 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

F2 · derivative.expiration_date: The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:16 UTC Exercise / conversionCommon stock 1,977 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000045 · wk-form4_1750191390.xml · nonDerivative · entry 1

CAPELLO JEFFREY D · CIK 0001224108 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,953

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 10, 2025 Filed Apr 10, 2025 20:02 UTC SaleCommon stock 7,497 $25.90 $194,172.30
Disclosure

SEC source: 0001439222-25-000029 · wk-form4_1744315371.xml · nonDerivative · entry 2

FOUSE JACQUALYN A · CIK 0001405288 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 149,220

F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated April 8, 2022.

Read SEC document
April 08, 2025 Filed Apr 10, 2025 20:02 UTC Exercise / conversionRestricted stock units · Derivative 15,933 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000029 · wk-form4_1744315371.xml · derivative · entry 3

FOUSE JACQUALYN A · CIK 0001405288 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 15,933 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units were granted on April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.

F3 · derivative.expiration_date: The restricted stock units were granted on April 8, 2022. Beginning on April 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
April 08, 2025 Filed Apr 10, 2025 20:02 UTC Exercise / conversionCommon stock 15,933 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000029 · wk-form4_1744315371.xml · nonDerivative · entry 1

FOUSE JACQUALYN A · CIK 0001405288 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 21:18 UTC
Viswanadhan KrishnanChief Corp Dev & Strategy
GrantStock options (right to buy) · Derivative 55,374 $0.00 Strike: $33.95 $0.00
Disclosure

SEC source: 0001439222-25-000027 · wk-form4_1741382325.xml · derivative · entry 2

Viswanadhan Krishnan · CIK 0001999913 · Chief Corp Dev & Strategy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,374

Underlying: Common stock · 55,374 shares

Expires 2035-03-05

F3 · derivative.exercise_date: This option was granted on March 5, 2025. The shares underlying this option vest as to 25% of the underlying shares on March 5, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.

Read SEC document
March 05, 2025 Filed Mar 7, 2025 21:18 UTC
Viswanadhan KrishnanChief Corp Dev & Strategy
GrantRestricted stock units · Derivative 24,300 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000027 · wk-form4_1741382325.xml · derivative · entry 1

Viswanadhan Krishnan · CIK 0001999913 · Chief Corp Dev & Strategy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,300

Underlying: Common stock · 24,300 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

F2 · derivative.expiration_date: The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:12 UTC
Milanova TsvetaChief Commercial Officer
SaleCommon stock 1,681 $35.54 $59,742.74
Disclosure

SEC source: 0001439222-25-000017 · wk-form4_1741122771.xml · nonDerivative · entry 2

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,892

F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:08 UTC
Gheuens SarahChief Medical Officer
SaleCommon stock 1,681 $35.54 $59,742.74
Disclosure

SEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · nonDerivative · entry 6

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,897

F4 · kind: hares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:08 UTC
Gheuens SarahChief Medical Officer
SaleCommon stock 1,187 $35.54 $42,185.98
Disclosure

SEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · nonDerivative · entry 4

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,911

F3 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:08 UTC
Gheuens SarahChief Medical Officer
SaleCommon stock 1,137 $35.54 $40,408.98
Disclosure

SEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · nonDerivative · entry 2

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,098

F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:17 UTC
Burns James WilliamChief Legal Officer
SaleCommon stock 1,681 $35.54 $59,742.74
Disclosure

SEC source: 0001439222-25-000021 · wk-form4_1741123013.xml · nonDerivative · entry 6

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,449

F4 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:17 UTC
Burns James WilliamChief Legal Officer
SaleCommon stock 1,187 $35.54 $42,185.98
Disclosure

SEC source: 0001439222-25-000021 · wk-form4_1741123013.xml · nonDerivative · entry 4

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,463

F3 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:17 UTC
Burns James WilliamChief Legal Officer
SaleCommon stock 1,137 $35.54 $40,408.98
Disclosure

SEC source: 0001439222-25-000021 · wk-form4_1741123013.xml · nonDerivative · entry 2

Burns James William · CIK 0001900772 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,650

F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:15 UTC
Jones CeciliaChief Financial Officer
SaleCommon stock 1,681 $35.54 $59,742.74
Disclosure

SEC source: 0001439222-25-000019 · wk-form4_1741122903.xml · nonDerivative · entry 4

Jones Cecilia · CIK 0001840056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,829

F3 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:15 UTC
Jones CeciliaChief Financial Officer
SaleCommon stock 594 $35.54 $21,110.76
Disclosure

SEC source: 0001439222-25-000019 · wk-form4_1741122903.xml · nonDerivative · entry 2

Jones Cecilia · CIK 0001840056 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,843

F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:10 UTC
Goff BrianDirector · Chief Executive Officer
SaleCommon stock 8,794 $35.54 $312,538.76
Disclosure

SEC source: 0001439222-25-000015 · wk-form4_1741122616.xml · nonDerivative · entry 4

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,345

F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:10 UTC
Goff BrianDirector · Chief Executive Officer
SaleCommon stock 4,153 $35.54 $147,597.62
Disclosure

SEC source: 0001439222-25-000015 · wk-form4_1741122616.xml · nonDerivative · entry 2

Goff Brian · CIK 0001546216 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 83,139

F1 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance share units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:06 UTC
Washburn Theodore James Jr.Principal Accounting Officer
Exercise / conversionRestricted stock units · Derivative 2,450 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000011 · wk-form4_1741122407.xml · derivative · entry 11

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,900

Underlying: Common stock · 2,450 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F10 · derivative.exercise_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

F10 · derivative.expiration_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:06 UTC
Washburn Theodore James Jr.Principal Accounting Officer
SaleCommon stock 727 $35.54 $25,837.58
Disclosure

SEC source: 0001439222-25-000011 · wk-form4_1741122407.xml · nonDerivative · entry 6

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,414

F4 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:06 UTC
Washburn Theodore James Jr.Principal Accounting Officer
SaleCommon stock 697 $35.54 $24,771.38
Disclosure

SEC source: 0001439222-25-000011 · wk-form4_1741122407.xml · nonDerivative · entry 4

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,691

F3 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.

Read SEC document
March 03, 2025 Filed Mar 4, 2025 21:06 UTC
Washburn Theodore James Jr.Principal Accounting Officer
SaleCommon stock 231 $35.54 $8,209.74
Disclosure

SEC source: 0001439222-25-000011 · wk-form4_1741122407.xml · nonDerivative · entry 2

Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,038

F2 · kind: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:12 UTC
Milanova TsvetaChief Commercial Officer
Exercise / conversionRestricted stock units · Derivative 5,667 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000017 · wk-form4_1741122771.xml · derivative · entry 5

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,333

Underlying: Common stock · 5,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F5 · derivative.exercise_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

F5 · derivative.expiration_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:12 UTC
Milanova TsvetaChief Commercial Officer
GrantStock options (right to buy) · Derivative 43,500 $0.00 Strike: $35.54 $0.00
Disclosure

SEC source: 0001439222-25-000017 · wk-form4_1741122771.xml · derivative · entry 4

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,500

Underlying: Common stock · 43,500 shares

Expires 2035-03-01

F4 · derivative.exercise_date: This option was granted on March 1, 2025. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:12 UTC
Milanova TsvetaChief Commercial Officer
GrantRestricted stock units · Derivative 12,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000017 · wk-form4_1741122771.xml · derivative · entry 3

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common stock · 12,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

F3 · derivative.expiration_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:12 UTC
Milanova TsvetaChief Commercial Officer
Exercise / conversionCommon stock 5,667 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000017 · wk-form4_1741122771.xml · nonDerivative · entry 1

Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,573

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:08 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionRestricted stock units · Derivative 5,667 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · derivative · entry 11

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 11,333

Underlying: Common stock · 5,667 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F10 · derivative.exercise_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

F10 · derivative.expiration_date: The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:08 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionRestricted stock units · Derivative 4,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · derivative · entry 10

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common stock · 4,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F9 · derivative.exercise_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.

F9 · derivative.expiration_date: The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:08 UTC
Gheuens SarahChief Medical Officer
Exercise / conversionRestricted stock units · Derivative 3,833 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · derivative · entry 9

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common stock · 3,833 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F8 · derivative.exercise_date: The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.

F8 · derivative.expiration_date: The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:08 UTC
Gheuens SarahChief Medical Officer
GrantStock options (right to buy) · Derivative 43,500 $0.00 Strike: $35.54 $0.00
Disclosure

SEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · derivative · entry 8

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,500

Underlying: Common stock · 43,500 shares

Expires 2035-03-01

F7 · derivative.exercise_date: This option was granted on March 1, 2025. The shares underlying this option vest as to 25% of the underlying shares on March 1, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 21:08 UTC
Gheuens SarahChief Medical Officer
GrantRestricted stock units · Derivative 12,000 $0.00 $0.00
Disclosure

SEC source: 0001439222-25-000013 · wk-form4_1741122508.xml · derivative · entry 7

Gheuens Sarah · CIK 0001881190 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Common stock · 12,000 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F6 · derivative.exercise_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

F6 · derivative.expiration_date: The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.